APA (7th ed.) Citation

MP, B., M, S., ES, D., MR, N., MR, P., SS, A., . . . RM, B. (2022). Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD. Clinical cardiology, 45(12), 1143. https://doi.org/10.1002/clc.23926

Chicago Style (17th ed.) Citation

MP, Bonaca, et al. "Efficacy and Safety of Rivaroxaban Versus Placebo After Lower Extremity Bypass Surgery: A Post Hoc Analysis of a "CASPAR like" Outcome from VOYAGER PAD." Clinical Cardiology 45, no. 12 (2022): 1143. https://doi.org/10.1002/clc.23926.

MLA (9th ed.) Citation

MP, Bonaca, et al. "Efficacy and Safety of Rivaroxaban Versus Placebo After Lower Extremity Bypass Surgery: A Post Hoc Analysis of a "CASPAR like" Outcome from VOYAGER PAD." Clinical Cardiology, vol. 45, no. 12, 2022, p. 1143, https://doi.org/10.1002/clc.23926.